Literature DB >> 23759675

Tumor imaging and interferon-γ-inducible protein-10 gene transfer using a highly efficient transferrin-conjugated liposome system in mice.

Huiqin Zhuo1, Yi Peng, Qin Yao, Nuo Zhou, Sufang Zhou, Jian He, Yuan Fang, Xi Li, Hongwei Jin, Xiaoling Lu, Yongxiang Zhao.   

Abstract

PURPOSE: We have developed a PEGylated transferrin-conjugated liposomes (PTf-Ls) system for the combined tumor imaging and targeted delivery of the IFN-γ-inducible protein-10 (IP-10) gene in a single macromolecular construct. Here, we characterize and analyze the use of this system in a mouse model of breast cancer. EXPERIMENTAL
DESIGN: The biophysical and cell transfection properties of PTf-Ls were determined through a series of in vitro experiments. A nude mouse/breast cancer cell line xenograft model (mouse xenograft model) was used to image the tumor internalization of fluorescently labeled PTf-Ls. The clinical use of the system was tested by treating tumor-bearing mice with PTf-Ls loaded with IP-10 plasmid DNA or fluorescent lipoplexes.
RESULTS: The resulting 165-nm liposomes (zeta potential = -10.6 mV) displayed serum resistance, low cytotoxicity (<5%), and high transfection efficiency (≤82.8%) in cultured cells. Systemic intravenous administration of fluorescent PTf-Ls in the mouse xenograft model resulted in nanoparticle circulation for 72 hours, as well as selective and efficient internalization in tumor cells, according to in vivo fluorescence and bioluminescence analyses. Tumor fluorescence increased gradually up to 26 hours, whereas background fluorescence decreased to near-baseline levels. Treatment of mice with PTf-Ls entrapped pcDNA3.1-IP-10 suppressed tumor growth in mice by 79% on day 50 and increased the mean survival time of mice. Fluorescent pcDNA-IP-10-entrapped PTf-Ls showed good properties for simultaneous tumor-targeted imaging and gene-specific delivery in an animal tumor model.
CONCLUSIONS: Our developed transferrin-conjugated liposome system possesses promising characteristics for tumor-targeting, imaging, and gene therapy applications. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23759675     DOI: 10.1158/1078-0432.CCR-12-3451

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  7 in total

1.  Use of luciferase probes to measure ATP in living cells and animals.

Authors:  Giampaolo Morciano; Alba Clara Sarti; Saverio Marchi; Sonia Missiroli; Simonetta Falzoni; Lizzia Raffaghello; Vito Pistoia; Carlotta Giorgi; Francesco Di Virgilio; Paolo Pinton
Journal:  Nat Protoc       Date:  2017-07-06       Impact factor: 13.491

2.  Reduced temporal sampling effect on accuracy of time-domain fluorescence lifetime Förster resonance energy transfer.

Authors:  Travis Omer; Lingling Zhao; Xavier Intes; Juergen Hahn
Journal:  J Biomed Opt       Date:  2014-08       Impact factor: 3.170

3.  Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding.

Authors:  Huifang Peng; Hongwei Jin; Huiqin Zhuo; Heqing Huang
Journal:  Oncotarget       Date:  2017-07-11

4.  Mouse IP-10 Gene Delivered by Folate-modified Chitosan Nanoparticles and Dendritic/tumor Cells Fusion Vaccine Effectively Inhibit the Growth of Hepatocellular Carcinoma in Mice.

Authors:  Zixi Hu; Jiaojiao Chen; Sufang Zhou; Nuo Yang; Siliang Duan; Zhenghua Zhang; Jing Su; Jian He; Zhiyong Zhang; Xiaoling Lu; Yongxiang Zhao
Journal:  Theranostics       Date:  2017-05-02       Impact factor: 11.556

5.  Efficient targeted tumor imaging and secreted endostatin gene delivery by anti-CD105 immunoliposomes.

Authors:  Huiqin Zhuo; Baoshi Zheng; Jianming Liu; Yong Huang; Huiling Wang; Duo Zheng; Naiquan Mao; Jinyu Meng; Sufang Zhou; Liping Zhong; Yongxiang Zhao
Journal:  J Exp Clin Cancer Res       Date:  2018-03-02

6.  Enhanced cytotoxic T lymphocytes recruitment targeting tumor vasculatures by endoglin aptamer and IP-10 plasmid presenting liposome-based nanocarriers.

Authors:  Xiaomei Yang; Jing Zhao; Siliang Duan; Xiaoqiong Hou; Xi Li; Zixi Hu; Zhuoran Tang; Fengzhen Mo; Xiaoling Lu
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

7.  Folate-modified Chitosan Nanoparticles Containing the IP-10 Gene Enhance Melanoma-specific Cytotoxic CD8(+)CD28(+) T Lymphocyte Responses.

Authors:  Jian He; Siliang Duan; Xia Yu; Zhiyong Qian; Sufang Zhou; Zhiyong Zhang; Xianing Huang; Yong Huang; Jing Su; Chunhui Lai; Jinyu Meng; Nuo Zhou; Xiaoling Lu; Yongxiang Zhao
Journal:  Theranostics       Date:  2016-03-21       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.